Showing results (1251-1260 of 1,547) with videos related to
Sort By:
Pageof 155
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed GlioblastomaMary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.Neurology|December 21, 2014
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningiomaAndrew D Norden, Keith L Ligon, Samantha N Hammond, et al.Nature|June 18, 2019
TOX is a critical regulator of tumour-specific T cell differentiationAndrew C Scott, Friederike Dündar, Paul Zumbo, et al.American Journal of Medical Genetics. Part A|December 6, 2011
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2Jaishri O Blakeley, D Gareth Evans, John Adler, et al.Journal of Neuro-Oncology|March 20, 2012
Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center studyWhitney B Pope, Xin Joe Qiao, Hyun J Kim, et al.Nature Biomedical Engineering|April 6, 2019
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithiumGiorgio Seano, Hadi T Nia, Kyrre E Emblem, et al.The Lancet. Oncology|January 5, 2024
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO groupNathalie L Albert, Norbert Galldiks, Benjamin M Ellingson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent GlioblastomaEudocia Q Lee, Brian M Alexander, Carlos G Romo, et al.Neuro-Oncology|January 31, 2016
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningiomaMalak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, et al.Journal of the National Cancer Institute|March 6, 2018
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation CarriersBritta Weigelt, Rui Bi, Rahul Kumar, et al.Pageof 155